Takeda Pharmaceutical to acquire Ariad for $5.2bn
MLex Summary: Takeda Pharmaceutical, a major Japanese drugmaker, will acquire Ariad Pharmaceuticals, a US company, for about $5.2 billion in cash through a tender offer. The transaction is subject to regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article